Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Long-Term Investments (2017 - 2024)

Historic Long-Term Investments for Qiagen (QGEN) over the last 8 years, with Q4 2024 value amounting to $3.2 million.

  • Qiagen's Long-Term Investments rose 295.17% to $3.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.2 million, marking a year-over-year increase of 295.17%. This contributed to the annual value of $3.2 million for FY2024, which is 295.17% up from last year.
  • Per Qiagen's latest filing, its Long-Term Investments stood at $3.2 million for Q4 2024, which was up 295.17% from $8.8 million recorded in Q2 2024.
  • In the past 5 years, Qiagen's Long-Term Investments registered a high of $379.1 million during Q4 2020, and its lowest value of $3.1 million during Q4 2023.
  • Over the past 5 years, Qiagen's median Long-Term Investments value was $144.5 million (recorded in 2023), while the average stood at $158.9 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first soared by 9716.43% in 2020, then tumbled by 9765.29% in 2023.
  • Over the past 5 years, Qiagen's Long-Term Investments (Quarter) stood at $379.1 million in 2020, then tumbled by 49.77% to $190.4 million in 2021, then tumbled by 31.02% to $131.4 million in 2022, then plummeted by 97.65% to $3.1 million in 2023, then increased by 2.95% to $3.2 million in 2024.
  • Its Long-Term Investments stands at $3.2 million for Q4 2024, versus $8.8 million for Q2 2024 and $55.7 million for Q1 2024.